Altre lingue Journey Medical Corporation

Azioni

DERM

US48115J1097

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 18/04/2024			Variaz. 5gg	Var. 1 gen.
3,58 ^USD	-7,25%		-16,94%	-37,85%

21/03	Transcript : Journey Medical Corporation, 2023 Earnings Call, Mar 21, 2024
21/03	Journey Medical Corporation riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights	21/03
Journey Medical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea	18/03
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea	18/03
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024	15/03
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference	13/03
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting	11/03
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 on Microbial Flora of Healthy Adults At 2024 Annual Meeting	11/03
Journey Medical Submits New Drug Application to FDA for Rosacea Treatment; Shares Rise	05/01
Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea	05/01
Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea	05/01
Journey Medical Signs Credit Facility of up to $20 Million	02/01
Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million	02/01
Journey Medical Corporation Secures Credit Facility with SWK Holdings for Up to $20 Million	02/01
Journey Medical Corporation Announces Resignation of Jeffrey Paley as Member of the Board of Directors	08/12
Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea	06/12
Journey Medical Corporation Announces Successful Completion of Pre-Nda Meeting with the Fda for Dfd-29 to Treat Rosacea	06/12
Journey Medical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11
Earnings Flash (DERM) JOURNEY MEDICAL CORPORATION Reports Q3 Revenue $34.5M	07/11
Earnings Flash (DERM) JOURNEY MEDICAL CORPORATION Posts Q3 EPS $0.99	07/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Journey Medical Corporation

Azioni

DERM

US48115J1097

Altre lingue

Filtri